- Press Release Distribution

Small but mighty new gene editor

Newly engineered CRISPR enzyme for editing DNA is more compact yet just as efficient as current popular tool, and could improve patient treatment

Small but mighty new gene editor

A new CRISPR-based gene-editing tool has been developed which could lead to better treatments for patients with genetic disorders. The tool is an enzyme, AsCas12f, which has been modified to offer the same effectiveness but at one-third the size of the Cas9 enzyme commonly used for gene editing. The compact size means that more of it can be packed into carrier viruses and delivered into living cells, making it more efficient. Researchers created a library of possible AsCas12f mutations and then combined selected ones to engineer an AsCas12f enzyme with 10 times more editing ability than the original unmutated type. This engineered AsCas12f has already been successfully tested in mice and has the potential to be used for new, more effective treatments for patients in the future.

By now you have probably heard of CRISPR, the gene-editing tool which enables researchers to replace and alter segments of DNA. Like genetic tailors, scientists have been experimenting with “snipping away” the genes that make mosquitoes malaria carriers, altering food crops to be more nutritious and delicious, and in recent years begun human trials to overcome some of the most challenging diseases and genetic disorders. The potential of CRISPR to improve our lives is so phenomenal that in 2020, researchers Jennifer Doudna and Emmanuelle Charpentier, who developed the most precise version of the tool named CRISPR-Cas9, were awarded the Nobel Prize in chemistry.

But even Cas9 has limitations. The common way to deliver genetic material into a host cell is to use a modified virus as a carrier. Adeno-associated viruses (AAVs) are not harmful to patients, can enter many different types of cells to introduce CRISPR enzymes like Cas9, and have a lower likelihood of provoking an undesired immune response compared to some other methods. However, like any parcel delivery service, there is a size limit. “Cas9 is at the very limit of this size restriction, so there has been a demand for a smaller Cas protein that can be efficiently packaged into AAV and serve as a genome-editing tool,” explained Professor Osamu Nureki from the Department of Biological Sciences at the University of Tokyo.

Its large size means that Cas9 can lack efficiency when used for gene therapy. So, a large multi-institutional team worked to develop a smaller Cas enzyme that is just as active, but more efficient. The researchers selected an enzyme called AsCas12f, from the bacteria Axidibacillus sulfuroxidans. The advantage of this enzyme is that it is one of the most compact Cas enzymes found to date and less than one-third the size of Cas9. However, in previous tests it showed barely any genome activity in human cells.

“Using a screening method called deep mutational scanning, we assembled a library of potential new candidates by substituting each amino acid residue of AsCas12f with all 20 types of amino acids on which all life is based. From this, we identified over 200 mutations that enhanced genome-editing activity,” explained Nureki. “Based on insights gained from the structural analysis of AsCas12f, we selected and combined these enhanced-activity amino acid mutations to create a modified AsCas12f. This engineered AsCas12f has more than 10 times the genome-editing activity compared to the usual AsCas12f type and is comparable to Cas9, while maintaining a much smaller size.”

The team has already carried out animal trials with the engineered AsCas12f system, partnering it with other genes and administering it to live mice. Administering treatments directly into the body is preferable to extracting cells, editing them in a lab and reinserting them into patients, which is more time-intensive and costly. The success of the tests showed that engineered AsCas12f has the potential to be used for human gene therapies, such as treating hemophilia, a disease in which the blood does not clot normally.

The team discovered numerous potentially effective combinations for engineering an improved AsCas12f gene-editing system, so the researchers acknowledge the possibility that the selected mutations may not have been the most optimal of all the available mixes. As a next step, computational modeling or machine learning could be used to sift through the combinations and predict which might offer even better improvements.

“Elevating AsCas12f to exhibit genome-editing activity comparable to that of Cas9 is a significant achievement and serves as a substantial step in the development of new, more compact genome-editing tools,” said Nureki. “For us the crucial aspect of gene therapy is its potential to genuinely help patients. Using the engineered AsCas12f we developed, our next challenge is to actually administer gene therapy to aid people suffering from genetic disorders.”




Paper Title:

Tomohiro Hino, Satoshi N. Omura, Ryoya Nakagawa, Tomoki Togashi, Satoru N. Takeda, Takafumi Hiramoto, Satoshi Tasaka, Hisato Hirano, Takeshi Tokuyama, Hideki Uosaki, Soh Ishiguro, Madina Kagieva, Hiroyuki Yamano, Yuki Ozaki, Daisuke Motooka, Hideto Mori, Yuhei Kirita, Yoshiaki Kise, Yuzuru Itoh, Satoaki Matoba, Hiroyuki Aburatani, Nozomu Yachie, Tautvydas Karvelis, Virginijus Siksnys, Tsukasa Ohmori, Atsushi Hoshino, Osamu Nureki. “An AsCas12f-based compact genome editing tool derived by deep mutational scanning and structural analysis” Cell.


This research was supported by the Research Council of Lithuania for the support of European Joint Programme on Rare Diseases project GET-READY (grant number S-EJPRD-21-1), Japan Foundation for Applied Enzymology, AMED Grant Numbers JP22fk0410037 and JP22ae0201007, AMED Grant Numbers JP233fa627001 and JP19am0401005, the Platform Project for Supporting Drug Discovery and Life Science Research from AMED under Grant Number JP22am0101115, and the Cabinet Office, Government of Japan, Public/Private R&D Investment Strategic Expansion Program (PRISM) Grant Number JPJ008000.

Useful Links :

Graduate School of Science:

Department of Biological Sciences:

Declaration of interests: 

T.H., S.N.O., R.N., S.M., T.O., A. H., O.N. have filed a patent application related to this work. The remaining authors declare no competing interests.

Research Contact:

Professor Osamu Nureki

Department of Biological Sciences

Graduate School of Science

The University of Tokyo

7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8654, Japan                                        


Tel.: 03-5841-4392

Press contact:
Mrs. Nicola Burghall
Public Relations Group, The University of Tokyo,
7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8654, Japan

About the University of Tokyo
The University of Tokyo is Japan's leading university and one of the world's top research universities. The vast research output of some 6,000 researchers is published in the world's top journals across the arts and sciences. Our vibrant student body of around 15,000 undergraduate and 15,000 graduate students includes over 4,000 international students. Find out more at or follow us on Twitter at @UTokyo_News_en.



[Attachments] See images for this press release:
Small but mighty new gene editor Small but mighty new gene editor 2 Small but mighty new gene editor 3


Study finds SARS-CoV-2-associated sepsis was more common, deadly than previously thought

Using data from Mass General Brigham’s electronic health records, Brigham researchers quantified the burden of SARS-CoV-2-associated sepsis early in the pandemic New research suggests that the virus responsible for COVID-19 was a more common and deadly cause of sepsis during the initial period of the pandemic than previously assumed. The study, led by investigators from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, used electronic health record (EHR) data from five Mass General Brigham hospitals to track the rate of SARS-CoV-2-associated ...

Use of electronic clinical data to track incidence and mortality for SARS-CoV-2–associated sepsis

About The Study: The results of this study of 431,000 inpatient encounters at five Massachusetts hospitals suggest that SARS-CoV-2–associated sepsis was common and had higher mortality than presumed bacterial sepsis early in the COVID-19 pandemic. These findings highlight the high burden of SARS-CoV-2–associated sepsis and demonstrate the utility of electronic health record-based algorithms to conduct surveillance for viral and bacterial sepsis.  Authors: Claire N. Shappell, M.D., M.P.H., of Brigham and Women’s Hospital in Boston, is the corresponding author.   To access the embargoed ...

Misinformation, trust, and use of ivermectin and hydroxychloroquine for COVID-19

About The Study: In this 50-state survey study of 13,438 adults who reported probable or definite COVID-19 infection, endorsement of misinformation about the COVID-19 pandemic, lack of trust in physicians or scientists, conspiracy-mindedness, and the nature of news sources were associated with receiving non–evidence-based treatment for COVID-19. These results suggest that the potential harms of misinformation may extend to the use of ineffective and potentially toxic treatments in addition to avoidance of health-promoting behaviors.  Authors: Roy ...

Neighborhood factors, individual stressors, and cardiovascular health among Black and white adults

About The Study: In this study of Black and white U.S. adults ages 45 and older, neighborhood-level factors, including safety and physical and social environments, and individual-level factors, including discrimination, attenuated racial disparities in cardiovascular health. Interventional approaches to improve ideal cardiovascular health that separately target neighborhood context and discrimination by gender and race are warranted.  Authors: Anika L. Hines, Ph.D., M.P.H., of the ...

New research reveals link between childhood mental health problems and quality of life for young adults

Children with mental health issues are more likely to have poor mental and physical health in their late teens and early 20s, and are at greater risk of social isolation, low educational attainment, financial difficulties and heavy substance use. That’s according to new research led by RCSI University of Medicine and Health Sciences, which examined a wide range of data from more than 5,000 children and young adults in Ireland.  The findings, published today in JAMA Network Open, are drawn from the ‘Growing up in Ireland’* study. The researchers from Ireland, the UK, and Australia followed trends of mental health throughout childhood (ages 9-13) for 5,141 ...

New insights into how the human brain organises language

Language is the most important tool for human communication and essential for life in our society. “Despite a great deal of neuroscientific research on the representation of language, little is known about the organisation of language in the human brain. Much of what we do know comes from single studies with small numbers of subjects and has not been confirmed in follow-up studies,” says Dr Sabrina Turker from the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig. This meta-analysis aims to help change that. Based on more than 400 ...

Visual search: Context facilitates more effective strategies

Study by LMU psychologists shows that distractor objects can help the visual system develop more effective search strategies. People are continuously provided with an overwhelming stream of events flooding the sensory organs. However, while the brain has impressive processing capabilities, its capacity is strongly limited. Thus, an observer cannot consciously experience all the events and information available at any one time, but has to focus on some limited subset of the whole. For many decades, researchers have investigated the neuro-cognitive mechanisms of this selective attention through the use of visual search and have shown that contextual cueing plays ...

Malaria: Treatment of Plasmodium falciparum malaria patients under threat in the Horn of Africa

Diagnosis of Plasmodium falciparum malaria using rapid diagnostic tests and treatment with artemisinin derivatives, the main component of the malaria treatments recommended by the World Health Organization (WHO), are under threat in the Horn of Africa. Scientists from the Laboratory of Parasitology and Medical Mycology at the University of Strasbourg and Strasbourg University Hospital, in collaboration with the Eritrean Ministry of Health, the Institut Pasteur, Columbia University in New York and WHO, have detected the emergence and spread in Eritrea of parasites with both artemisinin resistance and genome modifications ...

New post-translational modification of the glycolytic enzyme enolase

Tsukuba, Japan—Proteins are subject to post-translational chemical modifications that result in functional diversity. Methylation is one such modification that is generally believed to occur on lysine and arginine residues. Recently, this modification has been shown to occur on histidine residues as well. Furthermore, it has been suggested that histidine methylation occurs in a wide range of proteins. However, many details remain unknown: for example, which are the proteins that are methylated and ...

New frontier in biomedical engineering: Protein coacervates engineered into adhesive for unprecedented skin repair speed

New frontier in biomedical engineering: Protein coacervates engineered into adhesive for unprecedented skin repair speed
A team of researchers from China has made a significant breakthrough in biomedical engineering by developing a novel adhesive that promises to revolutionize wound management and tissue repair. The research, published in Engineering, unveils a biocomposite adhesive that exhibits robust adhesion and real-time skin healing properties. Adhesives have long been recognized as a valuable tool in biomedical engineering. However, current adhesive systems face challenges in achieving strong and durable adhesion, limiting their effectiveness in wound healing. ...


Mothers live longer as child mortality declines

Study reveals promising development in cancer-fighting nanotechnologies

Fat cells influence heart health in Chagas disease

C-Path’s TRxA announces its first biologics-focused RFP for academic investigators

Enhancing superconductivity of graphene-calcium superconductors

Federal Trade Commission actions on prescription drugs, 2000-2022

Fluoride exposure during pregnancy linked to increased risk of childhood neurobehavioral problems, study finds

The Ukraine war caused migrating eagles to deviate from their usual flight plan

Endangered migrating eagles impacted by Ukraine war

Study explores association between fluoride exposure in pregnancy and neurobehavioral issues in young children

Using magnetic resonance spectroscopy to design safer, higher-performance lithium batteries

Should your exercise goals be in minutes or steps? Study suggests they are equally beneficial

Racial and ethnic inequities in cancer care continuity during the COVID-19 pandemic among those with SARS-CoV-2

Effect of sleep restriction on adolescent cognition by adiposity

Webb Telescope offers first glimpse of an exoplanet’s interior

Alkyl-aromatic hybrid micelles formed from emergent umbrella-shaped molecules

First study from the African Ancestry Neuroscience Research Initiative identifies key genes in the brain that account for higher rates of some brain disorders in Black Americans

NIH awards Coast-to-Coast Consortium $5.6 million for All of Us Research Program

Ben-Gurion University scientist hunts for drug candidate to treat brain tumors

New Health Blueprint maps healthier future for rural, underserved Southwest Virginia

Survival benefit associated with participation in clinical trials of anticancer drugs

Expanding on the fundamental principles of liquid movement

Chemical Insights Research Institute partners with Duke University and the East-West Center to examine dust and ash from devastating Hawai’ian wildfires

NCCN publishes new resource for patients with intestinal cancer type most have never heard of before diagnosis

Subduction zone splay faults compound hazards of great earthquakes

Record low Antarctic sea ice ‘extremely unlikely’ without climate change

After hundreds of years, study confirms Bermuda now home to cownose rays

Scientists uncover promising treatment target for resistant brain cancer

Revolutionizing cancer treatment by intracellular protein delivery using hybrid nanotubes

Chemist Julian West makes C&EN magazine’s ‘Talented 12’ list

[] Small but mighty new gene editor
Newly engineered CRISPR enzyme for editing DNA is more compact yet just as efficient as current popular tool, and could improve patient treatment